HOPKINTON, Mass., June 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that it will hold a Customer Owner's Group (COG) meeting to be held June 9 and 10, 2010 at Caliper's Hopkinton headquarters. The company will webcast a separate Investor Breakout Session from 2:00 - 3:00 p.m. EDT on Thursday, June 10.
The investor portion of the conference will feature a presentation by Kevin Hrusovsky, President and CEO, who will outline Caliper's strategic priorities and the future direction of Caliper's technologies and services, followed by Q&A with a management panel. The Customer Open House sessions will include presentations from over two dozen of the company's customers highlighting their innovative uses of Caliper's technologies in drug discovery and development and molecular biology. The full agenda can be viewed at http://www.caliperls.com//products/cog2010.php.
Attendance at the event is by invitation only due to limited seating availability. Persons interested in reserving a seat should contact Cathy Portanova at email@example.com.
To participate in the call, please dial 888.679.8040 five to ten minutes prior to the call and use the participant passcode of 56829909. International callers may access the call by dialing 617.213.4851 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=P9AWLR9AW. A live webcast of the call can also be accessed on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page.
Telephone replays of the presentation will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from June 10 through June 17, dial 888.286.8010 and use the participant passcode of 93916636. International callers can access the playback by dialing 617.801.6888 and using the same participant passcode.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
Caliper is a registered trademark of Caliper Life Sciences, Inc.
SOURCE Caliper Life Sciences, Inc.